Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

astrazeneca-sign

AstraZeneca’s Farxiga cuts heart risk in type 2 diabetes patients

September 24, 2018 Research and Development, Sales and Marketing AstraZeneca, diabetes, farxiga, pharma

AstraZeneca has unveiled new Phase 3 data for its SGLT2 inhibitor Farxiga (dapagliflozin), showing with the drug demonstrating positive findings …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

September 21, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jobs, Novartis, Novo Nordisk, Senate, UCB, manufacturing, opioid crisis, top 10

Manufacturing took a hit this week as Novo Nordisk announced the loss of 400 jobs while Novartis made the move …
News

Shares in Molecular Templates surge after the announcement of Takeda collaboration

September 20, 2018 Business Services, Research and Development Molecular Templates, Shares, Takeda, markets, stocks

Shares in the Texas based biotech Molecular Templates have soared after the company announced that they would be collaborating with …
News
alzheimers_pharmafocus_accompanying_image

A goal in mind: Transforming the way Alzheimer’s disease is diagnosed and treated

September 20, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Roche, pharma

Dr Rachelle Doody, Global Head of Neurodegeneration at Roche/Genentech, discusses key learnings from clinical trials in Alzheimer’s disease, and how …
Feature

Astellas’ chronic kidney drug shows superiority at Phase 3

September 20, 2018 Research and Development Astellas, chronic kidney disease, pharma, roxadustat

Astellas has revealed new Phase 3 data for roxadustat in the treatment of chronic kidney disease (CKD) in patients with …
News
almirall-605x338

Almirall’s Ilumetri scores EU approval in chronic plaque psoriasis

September 19, 2018 Research and Development, Sales and Marketing Almirall, EADV 2018, Ilumetri, pharma, psoriasis

Hot on the heels of the European Academy of Dermatology and Venereology Congress (EADV) 2018 where psoriasis took centre stage, …
News
kymriah

NICE rejects CAR-T therapy Kymriah for DLBCL in adults

September 19, 2018 Research and Development CAR T, CAR-T, Kymriah, NICE, Novartis, leukaemia

The National Institute for health and Care Excellence (NICE) has rejected Novartis’ CAR-T therapy Kymriah for use in adults with …
News

Novartis to relocate Arnhem operations to Amsterdam, 400 jobs affected

September 19, 2018 Manufacturing and Production, Research and Development Netherlands, Novartis, amsterdam, pahrma, pharma

Novartis has announced it is to relocate its operations in Arnhem in the Netherlands to the capital city of Amsterdam, …
News
astrazeneca_plaque

AstraZeneca to increase presence in China

September 19, 2018 Research and Development AstraZeneca, China, alibaba, governemnt, tencent

The Anglo-Swedish multinational AstraZeneca is moving towards becoming a major healthcare provider in China as part of an effort to …
News
5204602349_c87b204860_z

FDA expand REMS education program in effort against opioid crisis

September 19, 2018 Research and Development FDA, IR, opioid crisis, opioids, rems

The US Food and Drug Administration is set to introduce a requirement that all healthcare providers be offered educational training …
News
cruk

Cancer Research UK announces new £14m research hub in London

September 18, 2018 Manufacturing and Production, Research and Development CRUK, Cancer, pharma

Cancer Research UK has announced a £14 million investment to build a new hub in London for cancer research and …
News

Sanofi’s Dupixent improves symptoms for adolescent atopic dermatitis patients

September 17, 2018 Research and Development, Sales and Marketing Dupixent, EADV 2018, Sanofi, atopic dermatitis, pharma

Sanofi’s Dupixent (dupilumab) has made a strong showing as a monotherapy at Phase 3 in the treatment of moderate-to-severe atopic …
News
georg-terstappen

Ex-GSK R&D head joins OxStem as CSO

September 14, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, OxStem, University of Oxford

OxStem, a regenerative drug discovery unit spun out from the University of Oxford, has brought on board ex-GlaxoSmithKline R&D exec …
Appointment

UCB brings promising plaque psoriasis data to EADV 2018

September 14, 2018 Medical Communications, Research and Development EADV 2018, UCB, pharma, psoriasis

UCB has joined in on the wave of new psoriasis data emerging from the European Academy of Dermatology and Venereology …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

September 14, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, FDA, NICE, Novo Nordisk, Spinraza, brexit, bristol myers squibb, top 10

With the Pharmafocus team having avoided hurricane Florence and finally arriving back in the UK just last night, after stopping …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025